CRBP SCHEDULE 13G/A: SEC filing

A Schedule 13G/A amendment was

Filed with the SEC on · accession 0000929638-26-004181

CRBP filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 2, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -7.2% by the first close after the filing.

Summary of the filing

A Schedule 13G/A amendment was filed regarding Corbus Pharmaceuticals Holdings, Inc. The filing indicates a change in ownership position by a holder, though specific details are not provided in the available text.

Key details

IssuerCorbus Pharmaceuticals Holdings, Inc.

How CRBP stock reacted

Close before

$4.22

Oct 30, 2026

First close after

-7.23%

$3.92

5 trading days

—

Since filing

-15.40%

$3.57

✦ Ask GOAX AI about this filing — what it means for CRBP, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CRBP?

Click here

Frequently asked questions

What did CRBP file with the SEC on Nov 2, 2026?

CRBP filed a SCHEDULE 13G/A (SEC filing). A Schedule 13G/A amendment was filed regarding Corbus Pharmaceuticals Holdings, Inc. The filing indicates a change in ownership position by a holder, though specific details are not provided in the available text.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did CRBP stock react to this filing?

CRBP closed at $4.22 before the filing and $3.92 on Nov 2, 2026 (-7.23%).

Other CRBP SEC filings

Get alerts when CRBP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days